Okan U. Elci
Acceleron Pharma (United States)(US)
Publications by Year
Research Areas
Congenital Heart Disease Studies, Ovarian function and disorders, Eating Disorders and Behaviors, Retinal Development and Disorders, Mobile Health and mHealth Applications
Most-Cited Works
- → Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial(2017)1,826 cited
- → Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial(2016)450 cited
- → Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy(2019)374 cited
- → The Effect of Electronic Self‐Monitoring on Weight Loss and Dietary Intake: A Randomized Behavioral Weight Loss Trial(2010)347 cited
- → Locally Advanced Squamous Cell Carcinoma of the Head and Neck: CT Texture and Histogram Analysis Allow Independent Prediction of Overall Survival in Patients Treated with Induction Chemotherapy(2013)202 cited
- → The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene(2018)129 cited
- → SMART trial: A randomized clinical trial of self-monitoring in behavioral weight management-design and baseline findings(2009)128 cited
- → Physical Activity Self-Monitoring and Weight Loss(2010)114 cited
- → Using a Personal Digital Assistant for Self-Monitoring Influences Diet Quality in Comparison to a Standard Paper Record among Overweight/Obese Adults(2011)97 cited
- → Improved Retention of Chest Compression Psychomotor Skills With Brief “Rolling Refresher” Training(2017)94 cited